Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Airbnb
TI
TickerTickle
Community Contributor
Airbnb (ABNB): Still one of the most interesting bets in travel
Key insights Airbnb is changing from a travel-only app to a full lifestyle platform (stays, rentals, experiences) International markets are growing faster than the US, which is slowing down Product experience is improving a lot, with AI making search and booking easier Regulations are becoming a big risk, especially in Europe where listings are getting removed The way people move around the world has changed. It’s not only about holidays anymore.
View narrative
US$163.75
FV
27.8% undervalued
intrinsic discount
12.00%
Revenue growth p.a.
Set Fair Value
4
users have liked this narrative
0
users have commented on this narrative
11
users have followed this narrative
New
narrative
ING Groep
PI
PittTheYounger
Community Contributor
ING leads the pack when it comes to pivoting towards non-lending income
ING, of course, is a bank; and banks don't like falling interest rates, right? For the dominant stream of income is their core business model, i.e. borrowing short-term and lending long-term, reaping the difference in interest rates in the process.
View narrative
€27.92
FV
25.2% undervalued
intrinsic discount
9.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
New
narrative
Coles Group
RO
Robbo
Community Contributor
Coles (ASX: COL): Safe, Steady, and Surprisingly Cheap
The supermarket chain Coles is the kind of “boring” business that may have been overlooked as an investment opportunity. Although it was divested from Wesfarmers in 2018, Coles’ heritage traces back to 1914 — giving it over 110 years of history.
View narrative
AU$22.00
FV
5.0% undervalued
intrinsic discount
8.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
TCI Express
AN
AnalystConsensusTarget
Consensus Narrative from 11 Analysts
Expanding Air Express And Multimodal Services Will Boost Customer Reach And Service Levels
Key Takeaways Expansion of delivery networks and multimodal services aims to diversify revenue streams and improve margins through higher-margin offerings. Investments in automation and IT infrastructure, supported by government initiatives, are set to enhance operational efficiency and reduce costs.
View narrative
₹838.45
FV
20.4% undervalued
intrinsic discount
7.92%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
5 days ago
author updated this narrative
Verve Group
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
ID-less Targeting And AI Investments Will Drive Future Success In Privacy-Focused Advertising
Key Takeaways Verve Group's ID-less targeting solutions and expansion into digital channels position it for revenue growth in a privacy-focused advertising market. Integration of Jun Group and investment in AI-driven solutions are expected to improve operational efficiencies and enhance net margins.
View narrative
€6.22
FV
59.3% undervalued
intrinsic discount
11.48%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 days ago
author updated this narrative
Südzucker
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Expected Sugar Market Shift And Positive Fruit Trends May Improve Future Margins
Key Takeaways Sugar market deficit could increase prices, benefiting Südzucker's revenue and margins long-term. EU-Mercosur agreement introduces gradual competitive pressures, allowing strategic adaptation to protect net margins.
View narrative
€11.06
FV
8.0% undervalued
intrinsic discount
1.14%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
8
users have followed this narrative
5 days ago
author updated this narrative
Novartis
AN
AnalystConsensusTarget
Consensus Narrative from 18 Analysts
China Expansion And Advanced Therapies Will Drive Future Upside
Key Takeaways Strong demand for innovative therapies and expansion in emerging markets support growth, while operational efficiency boosts margins and long-term profitability. Advancements in advanced therapies and substantial shareholder returns position the company for accelerated earnings and enhanced equity performance.
View narrative
CHF 98.79
FV
2.6% undervalued
intrinsic discount
2.22%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
82
users have followed this narrative
5 days ago
author updated this narrative
Union Bank of the Philippines
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Completion Of Citi Integration Will Enable Focus On Growth Initiatives By 2025
Key Takeaways Focus on consumer loans and strategic shifts aim to sustain high net interest margins, enhancing future revenue growth and profitability. Improved operational efficiency and increasing non-interest income from transaction services are expected to enhance earnings quality and net margins.
View narrative
₱42.58
FV
26.7% undervalued
intrinsic discount
24.20%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
45
users have followed this narrative
5 days ago
author updated this narrative
Strides Pharma Science
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Affordable Generics And Digital Trends Will Broaden Global Healthcare Reach
Key Takeaways Expansion in high-value generics, R&D investments, and digital transformation are driving diversified growth and long-term profitability across regulated and emerging markets. Streamlined product portfolio, cost optimization, and supply chain efficiencies are boosting margins and supporting sustainable earnings improvement.
View narrative
₹1.08k
FV
24.3% undervalued
intrinsic discount
12.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Metropolis Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 19 Analysts
Integration Of Core Diagnostics Will Strengthen Specialty Diagnostics Leadership
Key Takeaways Strategic acquisitions and high-tech expansions are expected to drive Metropolis' revenue growth and enhance specialty diagnostics leadership. Investment in technology and micro marketing strategies is set to improve patient engagement, operational efficiency, and optimize future revenue generation.
View narrative
₹1.94k
FV
8.1% overvalued
intrinsic discount
15.89%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
5 days ago
author updated this narrative
Rossari Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Capacity Expansions And Green Chemistry Will Unlock Southeast Asia Markets
Key Takeaways Capacity expansions, overseas investments, and integration of acquisitions are set to boost revenue growth, operating leverage, and strengthen earnings resilience through diversification. Ongoing R&D in green chemistry and expansion into premium, eco-friendly segments will help capture new markets, support margin growth, and align with global sustainability trends.
View narrative
₹870.00
FV
26.8% undervalued
intrinsic discount
16.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
5 days ago
author updated this narrative
Zydus Wellness
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanding Health Markets And Digital Channels Will Build Long-Term Value
Key Takeaways Expansion into high-growth wellness categories and strong brand equity are driving resilient revenue streams and supporting premium pricing power. Digital transformation and improved distribution are enhancing margin potential, while input cost stabilization aids further profitability gains.
View narrative
₹2.38k
FV
18.6% undervalued
intrinsic discount
10.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
5 days ago
author updated this narrative
Value any company in seconds
Popular companies